跳至主要内容
临床试验/NCT00127907
NCT00127907已完成4 期

Comparison of Epinephrine Associated With Vasopressin vs Epinephrine Alone in the Treatment of Out-of-hospital Cardiac Arrests

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 2,416 人开始时间: 2004年5月2日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
2,416
试验地点
2
主要终点
Survival at hospital admission

研究概览

简要总结

Recent studies have suggested that arginine-vasopressin could be more effective in the treatment of cardiac arrests. The last published study did not outline obvious improvements in the prognosis of all cardiac arrests but pointed out a possible increased survival rate when arginine-vasopressin is associated with epinephrine. The aim of this study is to compare the efficacy of two successive injections of epinephrine (1 mg) with two successive injections of epinephrine associated with arginine-vasopressin (40 UI) in out-of-hospital cardiac arrests occurring in adult patients. The primary endpoint is the survival rate at hospital admission. The inclusion period lasts 18 months and 2416 patients are planned to be enrolled.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Out-of-hospital medical cardiac arrest in adult patients.

排除标准

  • Traumatic cardiac arrest
  • Pregnancy
  • Patients younger than 18 years old or older than 85 years old

结局指标

主要结局

Survival at hospital admission

次要结局

  • ROSC (Return of spontaneous circulation) Survival at : H24, Day 28, hospital discharge and one year Neurological status at H24 and hospital discharge.

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验